HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Kirk R. Kanter Joseph M. Forbess Paul M. Kirshbom Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kanter, K. R. Articles by Kirshbom, P. M. Search for Related Content PubMed PubMed Citation Articles by Kanter, K. R. Articles by Kirshbom, P. M. Related Collections Valve disease

Ann Thorac Surg 2005;80:642-646
© 2005 The Society of Thoracic Surgeons

---

Original article: Cardiovascular

Redo Mitral Valve Replacement in Children

Division of Cardiothoracic Surgery, Department of Surgery, Emory University School of Medicine, and Children’s Healthcare of Atlanta at Egleston, Atlanta, Georgia

Accepted for publication February 14, 2005.

^_* Address reprint requests to Dr Kanter, Division of Cardiothoracic Surgery, Emory University School of Medicine, 1365 Clifton Road, Atlanta, GA 30322 (Email: kkanter{at}emory.edu).

Presented at the Fifty-first Annual Meeting of the Southern Thoracic Surgical Association, Cancun, Mexico, Nov 4–6, 2004.

BACKGROUND: Despite excellent results with current techniques of mitral valve repair, some children still require mitral valve replacement (MVR). Of necessity, a certain percentage of these children need valve rereplacement (redo MVR).

METHODS: Of 82 MVRs at our institution since 1988, 22 were redo MVRs in 21 children aged 1.4–21 years (mean 9.8 ± 5.6 years). Interval from initial MVR was 1 month to 18 years (mean 5.8 ± 4.9 years). Reoperation indication was primarily stenosis in 13 (usually pannus formation), regurgitation in 4, valve thrombosis or embolism in 4, and endocarditis in 1. The initial valve was mechanical in 18 and xenograft in 4.

RESULTS: During redo MVR, 8 of 22 (36%) patients had additional procedures including left ventricular outflow tract obstruction relief or aortic valve replacement in 4 and tricuspid valve repair in 2. The new mitral valve was mechanical in 20 and xenograft in 2. Median valve size increased from 21 mm to 25 mm although 7 valves were not upsized on rereplacement (average valve size increase was 3.3 ± 1 mm). Only 2 patients (9%) needed a new pacemaker. There were no hospital deaths. Six children developed end-stage heart failure and underwent successful cardiac transplantation 3 to 32 (mean 12.1 ± 10.0) months, postoperatively. On follow-up of 1 month to 7.7 years (mean 2.5 ± 2.3 years) there has been only one late death of an unrecognized coronary artery anomaly.

CONCLUSIONS: Redo MVR in children can be performed safely with low morbidity and mortality. A larger prosthesis can often be placed in these children. A surprisingly high percentage of patients eventually require transplantation, perhaps reflecting unnecessary delay in referral for redo MVR.

This article has been cited by other articles:

				K. Ackermann, G. Balling, A. Eicken, T. Gunther, C. Schreiber, and J. Hess Replacement of the systemic atrioventricular valve with a mechanical prosthesis in children aged less than 6 years: Late clinical results of survival and subsequent replacement J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 750 - 756. [Abstract] [Full Text] [PDF]